Articles by Sam M

A groundbreaking case report publication on the impact of rapid molecular testing on lung cancer patients

TEL AVIV, Israel, July 26, 2023 (Newswire.com)
–
Imagene, an emerging leader in AI-based precision oncology, is pleased to announce the publication of a case report in the Journal of Clinical Pathology. The report, titled “Artificial Intelligence (AI) Molecular Analysis Tool Assists in Rapid Treatment Decision in Lung Cancer” demonstrates the successful application of Imagene’s AI technology in rapid molecular testing for lung cancer patients, conducted as part of a joint prospective study with the Pathology Department at the Sourasky Medical Center.

The case report describes two patients in their early 40s who were admitted at the emergency room with severe headaches. Brain MRIs and CT scans revealed suspected metastatic lung cancer that was confirmed by a biopsy analysis at the pathology lab. The patients needed immediate intervention and could not afford to wait for comprehensive genomic profiling results. To allow prompt decisions without compromising the small amount of remaining tissue, Imagene’s rapid AI-based molecular testing was used as part of collaborative research. 

Prof. Dov Hershkovitz, Head of the Pathology Department at the Sourasky Medical Center, said, “The ability to use Imagene’s AI technology in these cases was a game-changer. It allowed us to bypass the usual lengthy waiting period associated with comprehensive genomic profiling. This technology is revolutionizing the way we diagnose patients, with the potential to improve outcomes and save lives.”

The Imagene algorithmic inference identified, within minutes, positive EGFR mutation, from the biopsy H&E image. A subsequent rapid RT-PCR test for EGFR mutations was indeed positive, allowing for immediate targeted treatment initiation and avoiding the need for whole brain radiation therapy. Both patients’ MRI scans after two months showed significant improvement with disappearance of the enhancement. A news channel also featured this case, including an interview with the patient. She shared her personal experience and highlighted the significant positive psychological impact that the rapid testing had on her.

“These real-life cases underscore the transformative potential of AI in precision oncology,” said Dean Bitan, Co-founder and CEO of Imagene. “Our technology enabled the medical team to make a rapid, informed treatment decision, ultimately saving precious time and improving the patient’s prognosis. We are proud to be at the forefront of this revolution, working hand-in-hand with leading medical centers on prospective studies to enhance patient care and impact patients’ lives.”

“One of the hardest things as an oncologist is to tell my patients we need to wait for a molecular diagnosis in order to start the optimal personalized treatment. It is groundbreaking to be able to have a molecular profile from the biopsy image within minutes,” added Prof. Ido Wolf, Head of Oncology, Sourasky Medical Center. “With the help of the rapid AI-based diagnoses, we are able to navigate patients’ journeys and make immediate informed treatment decisions that have such a great impact on our patients’ lives.” 

Imagene continues to pursue the advancement of AI in precision oncology, providing innovative solutions that enhance cancer patients’ care and streamline clinical workflows. This technology can make molecular testing accessible to all cancer patients, particularly those in under-tested populations.

About Imagene

Imagene is an emerging leader in AI-based precision oncology. The company leverages AI to profile, within minutes, a broad range of cancer biomarkers from a digitized biopsy image alone, providing physicians with immediate oncology intelligence to ensure optimal treatment for all cancer patients. Imagene’s multidisciplinary team of data scientists, biologists, software engineers, and medical experts is committed to scientific excellence and collaboration, advancing precision oncology, and improving patient outcomes.

For more information, please visit imagene-ai.com.

Contact Information:

Avital Rabani

Head of Marketing

[email protected]

Original Source:

Imagene’s AI-Based Molecular Profiling Revolutionizes Lung Cancer Diagnostics: Two Patients Receive Immediate Targeted Therapy, Avert Brain Radiation

The post Imagene’s AI-Based Molecular Profiling Revolutionizes Lung Cancer Diagnostics: Two Patients Receive Immediate Targeted Therapy, Avert Brain Radiation first appeared on Enrose Magazine.

The post Imagene’s AI-Based Molecular Profiling Revolutionizes Lung Cancer Diagnostics: Two Patients Receive Immediate Targeted Therapy, Avert Brain Radiation appeared first on IGP Beauty.

Fortifeye Vitamins Introduces Next Gen Zinc-Free Macular Defense

Zinc Free Macular Defense Fortifeye Next Gen Zinc Free Macular Defense
…

The post Fortifeye Vitamins Breaks New Ground With Next Gen Zinc-Free Macular Degeneration Formula first appeared on Enrose Magazine.

The post Fortifeye Vitamins Breaks New Ground With Next Gen Zinc-Free Macular Degeneration Formula appeared first on IGP Beauty.

Investigational young Fresh Frozen Plasma (yFFP®) Treatments Study YP042022 IRCM-2022-333

HOUSTON, July 25, 2023 (Newswire.com)
–
Golden Gift, a 501(c)(3) nonprofit organization in support of the therapeutic use of blood plasma from young donors in treating age-related conditions, has shared an early announcement of significantly beneficial clinical trial evidence for Fresh Frozen Plasma (yFFP) Treatments. Chronic conditions developing in our aging population are now currently accounting for 90% of the United States’ health care costs. A frightening fact for the youth of our country is that health care expenses for these patients are expected to reach $5 trillion by 2025. Who will pay for it? Band-aid medication is not the answer. In fact, the greatest risk factor for disease is the degeneration of the body that develops as we age. The real resolution of age-associated diseases arises from insights into understanding and supporting the fundamental biology of age changes. 

All animate and inanimate matter have the same universal molecular etiology. The science of physics indicates that genes do not drive the aging process, but the general loss of molecular organization does. Every organ and blood vessel in our body as we undergo our basic metabolism, replacement, and repair, experiences a movement towards spreading out or loss of energy. For example, hot coffee gets cold, balls roll down hill and 3-dimensional complex molecules cannot be created with accuracy indefinitely. Therefore, large organs and metabolic functions fail, and can no longer support the existence of the organism.

Age changes occur in every multicellular animal. As the system starts to lose the ability to create complex matricellular proteins, non-structural proteins that support cell function, it begins losing the ability to ‘run the system’ – your body. Longevity is determined by the ability to maintain the potential energetics of all molecules.

How long can one continue to make the necessary complex structures as the laws of physics work to break us down? Waves of changes in the dysfunctional proteome of the blood in the fourth, seventh, and eighth decades of life reflect this degeneration: https://pubmed.ncbi.nlm.nih.gov/31806903. As less optimal complex usable proteins begin to circulate through the blood stream, the body becomes less efficient and as a result, we age, and we get sick: https://pubmed.ncbi.nlm.nih.gov/31932806. 

The removal of old cells and other debris, such as through the apheresis process, may in-fact, slow degeneration, and create some immune modulation, and cell stimulation. Everyone can use modalities of calorie restriction, exercise, and supplements to enhance the functions of their cells. However due to the Second Law of Thermodynamics, eventually complex molecules within the milieu cannot be produced any longer and must be replaced: 
https://nyaspubs.onlinelibrary.wiley.com/doi/abs/10.1196/annals.1395.001

Young blood plasma, collected from sex-identified individuals between the ages of 18 – 25, reverses age-related profiles and initiates systemic rejuvenation by introducing 10K proteins, 5K peptides, 45 cytokines, 50 sex matched hormones and 1.84 billion exosomes per ml, along with minerals and gut microbiota metabolites from healthy volunteer donors at the peak of their reproductive maturity. What your body can no longer make, you can replace and really slow the aging process, enhance fitness, and ward off disease.

This concept is illustrated in patients with cardiac disease. Those with heart failure will produce higher levels of BNP (brain natriuretic peptide) due to the stress on the muscle and overall cardiac function. A 79-year-old male had his BNP drop from over 1,300 pg/ml to 705 pg/ml after a 2-liter exchange, and a 71-year-old male with severe heart failure saw his BNP drop from 6,800 pg/ml to 715 pg/ml with 1-liter of his old plasma out, and 3-liters from young donors in, over two days.

Aging is now understood as a gradual, progressive deterioration simultaneously affecting different organ systems. Those with a faster ‘Pace of Aging’ tend to experience more rapid aging-related declines in physical and cognitive functions, have a higher predisposition to disease, and an accelerated time to death. We call these epigenetic changes. “Genetics loads the gun, but environment shoots it.” 

Evidence suggests that interventions to slow Pace of Aging will slow the progression to disease development and works to extend health/life span. The DunedinPACE is a highly accurate and reliable single-time-point measure of methylation that quantifies an individual’s Pace of Aging by evaluating their present state health to different biological processes of a population that was followed for age changing markers over time. 

Epigenetic changes that slow aging are difficult to realize and maintain. Prolonged significant calorie restriction was shown to reduce DunedinPACE by only 2-3% after two years: https://doi.org/10.1038/s43587-022-00357-y. Clearly, an overall healthy exercise plan as part of anyone’s lifestyle has also been proven to reduce the rate of aging. However, due to the laws of physics, interventions without adding young molecules only work to a point. 

A DunedinPACE of 1 was established to reference an average rate of 1 year of biological aging per year of chronological aging. Among Dunedin Study participants, the range of values extends from just above 0.6 (indicating an aging rate nearly 40 percent slower than the norm) to nearly 1.4 (indicating an aging rate 40 percent faster than the norm).

Sensitive to all interventions, the DunedinPACE very importantly allows testing of treatments intended to extend health span and lifespan in humans. For example, a 67-year-old male participating in our study with Parkinson’s disease received 2.5-liters of young Fresh Frozen Plasma (yFFP) through three exchanges within thirty days. In four months, his DunedinPACE was reduced by 18% to 0.82. 

A similarly significant outcome was realized in four months by a 78-year-old female with a family history and personal signs of dementia. She received 1.8-liters of young plasma in two-infusions, reducing her DunedinPACE by 17% to 0.78.

Making an early announcement of significantly beneficial clinical trial documentation from an ongoing study is important from many viewpoints: clinicians practicing evidence-based medicine; future patients to whom the studies apply; patients currently participating in clinical trials; and scientists, investigators, and regulators who strive to balance continuing studies with disseminating data in confirmation of therapeutic advances as quickly as is reasonable.

Our Investigational young Fresh Frozen Plasma (yFFP) Treatments Study continues to treat patients in the major cities in Texas by more than a dozen IRB-registered Co-Investigators. Additional outcomes will be presented at RAADfest in September and at the A4M World Congress in December.

https://www.youngplasmastudy.com 

https://www.youtube.com/@dianginsbergmd-optimalhealth

All research in the United States involving human subjects must be reviewed by an Institutional Review Board (IRB), unless specifically exempted by a federal regulation. Review boards protect the rights, privacy, and health of the research subjects in determining research will be conducted in a safe and ethical manner.

The Institute of Regenerative and Cellular Medicine
Barbara Krutchkoff, PhD., Executive Director
[email protected] / Phone: (888) 664-8893

IRB Registration Number: IRB00009500
IRB Parent/Organization Number: IORG0007913

Contact Information:

Dian Ginsberg, MD

Principle Investigator

[email protected]

(281) 569-4289

Related Files
Golden Gift Parkinson’s Disease study.pdf
Ginsberg YP042022v2 9.31.22 Approval.pdf

Original Source:

Early Announcement of Significantly Beneficial Clinical Trial Evidence From Young Blood Plasma Treatments

The post Early Announcement of Significantly Beneficial Clinical Trial Evidence From Young Blood Plasma Treatments first appeared on Enrose Magazine.

The post Early Announcement of Significantly Beneficial Clinical Trial Evidence From Young Blood Plasma Treatments appeared first on IGP Beauty.

Non-Profit Healthcare Organization Expands National Donor Engagement Efforts

Terry Dyer CAN Community Health hires Terry Dyer as Director of Dono…

The post CAN Community Health Names Terry Dyer as Director of Donor Development first appeared on Enrose Magazine.

The post CAN Community Health Names Terry Dyer as Director of Donor Development appeared first on IGP Beauty.

Financial Assistance From The Assistance Fund Now Available for Eligible People Living With Small Cell Lung Cancer

ORLAND…

The post The Assistance Fund Opens New Program for Small Cell Lung Cancer first appeared on Enrose Magazine.

The post The Assistance Fund Opens New Program for Small Cell Lung Cancer appeared first on IGP Beauty.

Continuing to provide a full spectrum of eating disorder treatment, four Selah House Outpatient clinics have rebranded as Aster Springs Outpatient with a new location coming to Richmond, Virginia.

…

The post Odyssey Unveils Rebrand of Eating Disorder Outpatient Clinics to Support Strategic Vision and Accelerated Growth first appeared on Enrose Magazine.

The post Odyssey Unveils Rebrand of Eating Disorder Outpatient Clinics to Support Strategic Vision and Accelerated Growth appeared first on IGP Beauty.

SAN FRANCISCO, July 24, 2023 (Newswire.com)
–
A recent peer-reviewed study published in the American Journal of Clinical Oncology demonstrates tumor bed delin…

The post Study Indicates Superiority of VeraForm Marker Over Clips During Breast Cancer Surgery first appeared on Enrose Magazine.

The post Study Indicates Superiority of VeraForm Marker Over Clips During Breast Cancer Surgery appeared first on IGP Beauty.

York Nordic is pleased to announce the introduction of the new Motivator walking poles with a newly designed ergonomic grip that lends support to Nordic Walking to ensure maximum benefit and comfort to the user.

SOMERSWORTH, N.H., July 24, 2023 (Newswire.com)
–
York Nordic is pleased to announce the introduction of the new Motivator walking poles with a newly designed ergonomic grip.

Research supports and proves that the act of Nordic Walking actually offers more health benefits than regular walking, jogging, biking and running. (Health Benefits — ANWA.us — americannordicwalking.com) York Nordic’s new Motivator walking poles have a newly designed ergonomic grip that lends support to Nordic Walking to ensure maximum benefit and comfort to the user. As with York Nordic’s other walking poles, the new Motivator is available in 20 custom designs that provide style and flair.

Lauren DeLong, the creator of the Motivator, noted “The Motivator offers patented (pending) contoured grips with two thumb support positions to stabilize the trapeziometacarpal joint and reduce strain on the carpometacarpal (CMC) thumb joint. This never seen before strapless grip design improves proprioception and offers state of the art ergonomics and best in class hand support for the biaxial saddle joint. The result is a 10 times reduction in stress at CMC joint minimizing torsional load while providing balance and stability to the patient looking for motivation to begin walking more confidently.”

In addition to general health benefits, Nordic Walking has been shown to aide those living with Parkinson’s Disease, MS and osteoarthritic hips and knees by aiding stability and developing strength.

York Nordic was founded by Lauren, who is also a certified Nordic Walking instructor, when she decided to design and manufacture her own poles after finding most poles lacked quality, style, and key features for different age groups and physical abilities. The poles are sold nationally and have been used in classes and health studies throughout the U.S. Visit www.yorknordic.com.

Contact Information:

Lauren DeLong

Owner

[email protected]

207-752-7298

Original Source:

York Nordic Introduces New ‘Motivator’ Walking Poles With Ergonomic Grip

The post York Nordic Introduces New ‘Motivator’ Walking Poles With Ergonomic Grip first appeared on Enrose Magazine.

The post York Nordic Introduces New ‘Motivator’ Walking Poles With Ergonomic Grip appeared first on IGP Beauty.

Restructuring enhances operations of the leader in online ADHD assessment and diagnosis and positions the company for growth.

…

The post ADHD Online Unveils a New Corporate Structure, Announces Series AA Investment, Establishes a New Board, and Appoints New CEO first appeared on Enrose Magazine.

The post ADHD Online Unveils a New Corporate Structure, Announces Series AA Investment, Establishes a New Board, and Appoints New CEO appeared first on IGP Beauty.

Virtual care company’s commitment to providing high-quality, delightful healthcare experiences is evolving workplace well-being.

CHICAGO, July 20, 2023 (Newswire.com)
–
First Stop Health (FSH), a leading virtual care company for primary, urgent and mental health care needs, is proud to announce its recognition as a winner of the esteemed 2023 Well-Being Trailblazer Award. Presented by Archetype and the Wellness Council of America (WELCOA), this prestigious award celebrates FSH’s contributions to the well-being industry and its commitment to transforming workplace wellness. 

“When we provide new services, we do so for the betterment of our users – employees and their family members across the country. That desire is what drove our decision to launch Virtual Primary Care in 2022,” said FSH CEO, Teira Gunlock. “We are excited to be considered a Trailblazer for our approach in delivering convenient, compassionate care.” 

“These remarkable companies are leading the way in transforming the well-being landscape, and we have full confidence that they will continue to drive positive change in the sphere of workplace well-being,” commented Iain Fitzpatrick, Chief Strategy Officer at Archetype. “Their innovative approaches and unwavering commitment to improving employee well-being are shaping the future of the industry.” 

Presented by Archetype and the Wellness Council of America (WELCOA), the Well-Being Trailblazer Awards celebrate innovative companies reshaping workplace wellness. These prestigious awards recognize organizations enhancing employee well-being, promoting resilience, and setting new standards for well-being technology, products, and services. 

FSH is proud to provide care that people love^® and its +94 Virtual Primary Care Net Promoter Score (NPS) reflects its commitment to members’ well-being. FSH virtual care is designed to promote equitable, culturally competent and quality-assured healthcare to support the unique needs of patients. 

About First Stop Health 

First Stop Health (FSH) provides care that people love with various digital healthcare services. Patients can access virtual care 24/7 via app, website or phone. We help them save time and money with safe, convenient, high-quality virtual care solutions – Primary Care, Urgent Care & Mental Health. FSH was named one of Inc. Magazine’s Best Workplaces of 2022 and 2023, and ranked one of the fastest-growing private companies for the past five years by Inc. 5000. FSH was also recognized in Crain’s Chicago Business Fast 50 and ranked one of the Chicago area’s fastest-growing companies.    

Contact Information:

Emily Kunisch

Senior Manager, Marketing

[email protected]

888-691-7867 x-410

Original Source:

First Stop Health Honored as Winner of the 2023 Well-Being Trailblazer Award

The post First Stop Health Honored as Winner of the 2023 Well-Being Trailblazer Award first appeared on Enrose Magazine.

The post First Stop Health Honored as Winner of the 2023 Well-Being Trailblazer Award appeared first on IGP Beauty.